22nd Jan 2026 EORTC 1333/PEACE-3 research on enzalutamide with or without radium-223 for advanced prostate cancer patients with bone metastases: a plain language summary
13th May 2025 Real-world survival rates for advanced prostate cancer patients using abiraterone or enzalutamide treatments: a plain language summary
12th Apr 2023 Plain Language Summary: managing metastatic prostate cancer by integrating radium-223 therapy
